CING.NASDAQCingulate INC

DEF 14A: Cingulate Inc. Seeks Stockholder Approval for Reverse Stock Split to Avoid Nasdaq Delisting

Sentiment:

Proxy Statement


Cingulate Inc. is asking stockholders to approve a reverse stock split, ranging from 1:2 to 1:15, to regain compliance with Nasdaq's minimum bid price requirement and avoid potential delisting.

Worse than expectedThe company received a delisting notice from Nasdaq due to non-compliance with the minimum bid price requirement, indicating worse than expected financial performance.

Summary

  • Cingulate Inc. is holding a special meeting on July 30, 2024, to seek stockholder approval for a reverse stock split.
  • The proposed reverse stock split aims to increase the company's stock price to meet Nasdaq's minimum bid price requirement of $1.00 per share.
  • The reverse stock split ratio will range from 1:2 to 1:15, with the exact ratio to be determined by the Board of Directors without further stockholder approval.
  • The Board also seeks approval to adjourn the special meeting if necessary to solicit additional proxies.
  • The company received a delisting notice from Nasdaq on June 17, 2024, due to non-compliance with the minimum bid price requirement.
  • As of June 14, 2024, Cingulate had 7,345,049 outstanding shares of common stock.
  • If the reverse stock split is approved, the number of outstanding shares will decrease to between 489,670 and 3,672,525, depending on the chosen ratio.
  • The Board reserves the right to abandon the reverse stock split if it's no longer in the company's best interest.
  • The reverse split will not change the number of authorized shares, which remains at 240,000,000.
  • The company's common stock closed at $0.661 per share on Nasdaq on June 14, 2024.

Sentiment

Score: 4

Explanation: The document is primarily focused on addressing a negative situation (potential delisting). While the reverse stock split is presented as a potential solution, there's no guarantee of success, and the company's future performance remains uncertain.

Positives

  • The reverse stock split aims to increase the stock price, potentially regaining compliance with Nasdaq listing rules.
  • A higher stock price could improve marketability and liquidity, attracting a broader range of institutional investors.
  • Increased stock price may encourage analyst and broker interest.
  • The reverse split will result in an effective increase in the authorized number of shares of common stock.
  • The Board recommends voting FOR the reverse split and adjournment proposals.

Negatives

  • There is no guarantee that the reverse stock split will increase the stock price or maintain compliance with Nasdaq listing rules.
  • The market price may decrease due to factors unrelated to the reverse stock split.
  • A decline in the stock price after the reverse split could result in a greater percentage decline.
  • The reverse stock split may decrease the liquidity of the common stock due to the reduced number of outstanding shares.
  • Delisting from Nasdaq could adversely affect the liquidity of the common stock.

Risks

  • Failure to regain compliance with Nasdaq listing rules could lead to delisting.
  • The reverse stock split may not increase the stock price as expected.
  • The market price of the common stock may decrease after the reverse stock split.
  • Reduced liquidity of the common stock after the reverse stock split.
  • The company may fail to meet other continued listing requirements, such as minimum stockholders' equity.

Future Outlook

The company intends to present a plan to regain compliance with the Minimum Bid Price Requirement at the Nasdaq Hearings Panel. The company will continue to take definitive steps, including the approval of the Reverse Split, in an effort to evidence compliance with the Minimum Bid Price Requirement.

Management Comments

  • The Board has determined that it is advisable and in the best interests of the Company and its stockholders to authorize our Board to amend our Charter to effect a reverse stock split.
  • Management and the Board have considered the potential harm to us and our stockholders should Nasdaq delist our common stock from trading.

Industry Context

Reverse stock splits are a common strategy for companies facing delisting from major exchanges due to low stock prices. This action aims to increase the stock price and attract a broader range of investors, but its success is not guaranteed and depends on various market factors and company performance.

Comparison to Industry Standards

  • Many companies facing Nasdaq delisting due to the minimum bid price requirement have implemented reverse stock splits.
  • The success of a reverse stock split varies widely, with some companies successfully regaining compliance and others continuing to struggle.
  • Comparable companies that have recently undergone reverse stock splits include those in the biotechnology and pharmaceutical sectors facing similar listing challenges.
  • The effectiveness of the reverse stock split depends on the company's underlying financial health and future growth prospects, as well as overall market conditions.

Stakeholder Impact

  • Shareholders will be impacted by the reverse stock split, potentially seeing a change in the number of shares they own and the stock price.
  • Employees may be affected by the company's ability to remain listed on Nasdaq, which could impact morale and stock option values.
  • The company's customers and suppliers may be indirectly affected by the company's financial stability and access to capital.

Next Steps

  • Stockholders will vote on the reverse stock split proposal at the Special Meeting on July 30, 2024.
  • The Board of Directors will determine the specific reverse stock split ratio if the proposal is approved.
  • The company will present its plan to regain compliance with Nasdaq listing rules at the Nasdaq Hearings Panel.
  • If approved, the company will file the Charter Amendment with the Secretary of State of the State of Delaware to effect the reverse stock split.

Key Dates

DateDescription
June 14, 2024Record date for determination of stockholders entitled to vote at the Special Meeting.
June 14, 2024Common stock closed at $0.661 per share on Nasdaq.
June 17, 2024Company received written notice from Nasdaq regarding non-compliance with the $1.00 Minimum Bid Price Requirement.
June 28, 2024Mailing date of proxy materials to stockholders.
July 30, 2024Date of the Special Meeting of Stockholders.
December 27, 2024Deadline for stockholder proposals to be included in the 2025 proxy materials.
February 11, 2025Earliest date for notice of director nominations or other business to be brought before the 2025 Annual Meeting.
March 13, 2025Latest date for notice of director nominations or other business to be brought before the 2025 Annual Meeting.
April 12, 2025Deadline for stockholders to provide notice of intent to solicit proxies in support of director nominees other than Cingulate's nominees.
May 21, 2025End of discretionary panel monitor period.

Keywords

reverse stock split, Nasdaq, delisting, common stock, proxy statement, stockholders, compliance, minimum bid price, Cingulate Inc.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.